PT  - JOURNAL ARTICLE
AU  - Polona Rajar
AU  - Ola D. Saugstad
AU  - Dag Berild
AU  - Anirban Dutta
AU  - Gorm Greisen
AU  - Ulrik Lausten-Thomsen
AU  - Sharmila S. Mande
AU  - Sushma Nangia
AU  - Fernanda C. Petersen
AU  - Ulf R. Dahle
AU  - Kirsti Haaland
TI  - Antibiotic stewardship in premature infants: a systematic review
AID  - 10.1101/2020.04.10.20060988
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.10.20060988
4099  - http://medrxiv.org/content/early/2020/04/14/2020.04.10.20060988.short
4100  - http://medrxiv.org/content/early/2020/04/14/2020.04.10.20060988.full
AB  - Antibiotic treatment in premature infants is often empirically prescribed, and practice varies widely among otherwise comparable neonatal intensive care units. Unnecessary and prolonged antibiotic treatment is documented in numerous studies. Recent research shows serious side effects and suggests long-term adverse health effects in prematurely born infants exposed to antibiotics in early life. One preventive measure to reduce unnecessary antibiotic exposure is implementation of antibiotic stewardship programs. We reviewed the literature on implemented antibiotic stewardship programs focusing on premature infants. Six academic databases were systematically searched and eleven articles met inclusion criteria. Articles were grouped according to common area of stewardship actions; 1) Focus on reducing initiation of antibiotic therapy, 2) Focus on shortening duration of antibiotic therapy, 3) Various infrastructural stewardship implementations. The studies differed in their cohort composition and measured outcomes. We provide an overview of the reduction in antibiotic use achieved. Antibiotic stewardship programs are effective especially when they use a multifactorial approach and are tailored to premature infants. Implementation of antibiotic stewardship programs targeting premature infants should be considered in all neonatal intensive care units. The Norwegian Research Council (project number 273833) and the Olav Thon Foundation supported the study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Norwegian Research Council (project number 273833) and the Olav Thon Foundation supported the study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable. As this is a systematic literature review, no original data was created.